PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2200.0
(0.0%)
IDR 2200.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1992.05 Billion IDR | 9.31% |
| 2022 | 1868.45 Billion IDR | 5.5% |
| 2021 | 1770.98 Billion IDR | 4.72% |
| 2020 | 1691.09 Billion IDR | -0.99% |
| 2019 | 1707.92 Billion IDR | 9.77% |
| 2018 | 1555.92 Billion IDR | 4.43% |
| 2017 | 1489.97 Billion IDR | -0.25% |
| 2016 | 1493.76 Billion IDR | 6.47% |
| 2015 | 1403.02 Billion IDR | 9.19% |
| 2014 | 1284.92 Billion IDR | 12.55% |
| 2013 | 1141.64 Billion IDR | 23.75% |
| 2012 | 922.56 Billion IDR | 20.64% |
| 2011 | 764.74 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 447.19 Billion IDR | 45.29% |
| 2024 Q1 | 449.15 Billion IDR | -18.87% |
| 2024 Q2 | 513.15 Billion IDR | 14.25% |
| 2023 Q3 | 489.64 Billion IDR | -4.64% |
| 2023 FY | 2042.44 Billion IDR | 9.31% |
| 2023 Q1 | 464.38 Billion IDR | -3.38% |
| 2023 Q2 | 513.49 Billion IDR | 10.57% |
| 2023 Q4 | 553.65 Billion IDR | 13.07% |
| 2022 Q1 | 454.79 Billion IDR | -3.51% |
| 2022 FY | 1868.45 Billion IDR | 5.5% |
| 2022 Q4 | 480.63 Billion IDR | 2.0% |
| 2022 Q3 | 471.21 Billion IDR | 2.03% |
| 2022 Q2 | 461.82 Billion IDR | 1.55% |
| 2021 Q3 | 437.59 Billion IDR | 1.14% |
| 2021 Q2 | 432.65 Billion IDR | 0.76% |
| 2021 Q4 | 471.34 Billion IDR | 7.71% |
| 2021 Q1 | 429.39 Billion IDR | -4.85% |
| 2021 FY | 1770.98 Billion IDR | 4.72% |
| 2020 Q1 | 425.24 Billion IDR | -6.46% |
| 2020 FY | 1691.09 Billion IDR | -0.99% |
| 2020 Q2 | 432.76 Billion IDR | 1.77% |
| 2020 Q3 | 381.77 Billion IDR | -11.78% |
| 2020 Q4 | 451.3 Billion IDR | 18.21% |
| 2019 FY | 1707.92 Billion IDR | 9.77% |
| 2019 Q3 | 435.8 Billion IDR | 7.61% |
| 2019 Q4 | 454.61 Billion IDR | 4.32% |
| 2019 Q1 | 412.51 Billion IDR | 0.35% |
| 2019 Q2 | 404.99 Billion IDR | -1.82% |
| 2018 Q2 | 372.29 Billion IDR | -4.3% |
| 2018 Q1 | 389 Billion IDR | -1.89% |
| 2018 Q4 | 411.05 Billion IDR | 7.17% |
| 2018 FY | 1555.92 Billion IDR | 4.43% |
| 2018 Q3 | 383.57 Billion IDR | 3.03% |
| 2017 Q2 | 361.43 Billion IDR | -0.86% |
| 2017 FY | 1489.97 Billion IDR | -0.25% |
| 2017 Q4 | 396.51 Billion IDR | 7.91% |
| 2017 Q3 | 367.46 Billion IDR | 1.67% |
| 2017 Q1 | 364.56 Billion IDR | -8.68% |
| 2016 Q4 | 399.2 Billion IDR | 14.97% |
| 2016 FY | 1493.76 Billion IDR | 6.47% |
| 2016 Q3 | 347.21 Billion IDR | -8.37% |
| 2016 Q2 | 378.91 Billion IDR | 2.84% |
| 2016 Q1 | 368.43 Billion IDR | -6.24% |
| 2015 FY | 1403.02 Billion IDR | 9.19% |
| 2015 Q4 | 392.95 Billion IDR | 16.07% |
| 2015 Q3 | 338.54 Billion IDR | 0.03% |
| 2015 Q2 | 338.43 Billion IDR | 1.6% |
| 2015 Q1 | 333.08 Billion IDR | -2.98% |
| 2014 FY | 1284.92 Billion IDR | 12.55% |
| 2014 Q4 | 343.33 Billion IDR | 7.5% |
| 2014 Q3 | 319.39 Billion IDR | 4.33% |
| 2014 Q2 | 306.12 Billion IDR | -3.15% |
| 2014 Q1 | 316.07 Billion IDR | 0.67% |
| 2013 Q4 | 313.97 Billion IDR | -4.62% |
| 2013 FY | 1141.64 Billion IDR | 23.75% |
| 2013 Q1 | 263.38 Billion IDR | 3.22% |
| 2013 Q2 | 235.08 Billion IDR | -10.75% |
| 2013 Q3 | 329.19 Billion IDR | 40.03% |
| 2012 Q1 | 215.94 Billion IDR | 0.0% |
| 2012 FY | 922.56 Billion IDR | 20.64% |
| 2012 Q3 | 229.2 Billion IDR | 3.13% |
| 2012 Q4 | 255.17 Billion IDR | 11.33% |
| 2012 Q2 | 222.24 Billion IDR | 2.92% |
| 2011 FY | 764.74 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 100.18 Billion IDR | -1888.349% |
| PT Kimia Farma (Persero) Tbk | 4350.51 Billion IDR | 54.211% |
| PT Millennium Pharmacon International Tbk | 184.42 Billion IDR | -980.164% |
| PT Soho Global Health Tbk | 851.38 Billion IDR | -133.978% |